223 related articles for article (PubMed ID: 33747936)
1. Genomic Mutation Profile of Primary Gastrointestinal Diffuse Large B-Cell Lymphoma.
Li P; Chai J; Chen Z; Liu Y; Wei J; Liu Y; Zhao D; Ma J; Wang K; Li X; Shao Y; Gong L; Zhang W; Guo S; Yan Q; Li M; Fan L; Wang Z
Front Oncol; 2021; 11():622648. PubMed ID: 33747936
[TBL] [Abstract][Full Text] [Related]
2. Whole-exome sequencing analysis identifies distinct mutational profile and novel prognostic biomarkers in primary gastrointestinal diffuse large B-cell lymphoma.
Li SS; Zhai XH; Liu HL; Liu TZ; Cao TY; Chen DM; Xiao LX; Gan XQ; Cheng K; Hong WJ; Huang Y; Lian YF; Xiao J
Exp Hematol Oncol; 2022 Oct; 11(1):71. PubMed ID: 36243813
[TBL] [Abstract][Full Text] [Related]
3. EZH2 overexpression in primary gastrointestinal diffuse large B-cell lymphoma and its association with the clinicopathological features.
Liu Y; Yu K; Li M; Zeng K; Wei J; Li X; Liu Y; Zhao D; Fan L; Yu Z; Wang Y; Li Z; Zhang W; Bai Q; Yan Q; Guo Y; Wang Z; Guo S
Hum Pathol; 2017 Jun; 64():213-221. PubMed ID: 28438623
[TBL] [Abstract][Full Text] [Related]
4. The Mutation of
Guo D; Hong L; Ji H; Jiang Y; Lu L; Wang X; Huang H
J Inflamm Res; 2022; 15():1757-1769. PubMed ID: 35300216
[TBL] [Abstract][Full Text] [Related]
5. Mutation landscape in Chinese nodal diffuse large B-cell lymphoma by targeted next generation sequencing and their relationship with clinicopathological characteristics.
Cao B; Sun C; Bi R; Liu Z; Jia Y; Cui W; Sun M; Yu B; Li X; Zhou X
BMC Med Genomics; 2024 Apr; 17(1):84. PubMed ID: 38609996
[TBL] [Abstract][Full Text] [Related]
6. Comprehensive Genomic Profiling of EBV-Positive Diffuse Large B-cell Lymphoma and the Expression and Clinicopathological Correlations of Some Related Genes.
Zhou Y; Xu Z; Lin W; Duan Y; Lu C; Liu W; Su W; Yan Y; Liu H; Liu L; Zhong M; Zhou J; Zhu H
Front Oncol; 2019; 9():683. PubMed ID: 31403034
[TBL] [Abstract][Full Text] [Related]
7. Genomic Analyses Identify Recurrent Alterations in Immune Evasion Genes in Diffuse Large B-Cell Lymphoma, Leg Type.
Zhou XA; Louissaint A; Wenzel A; Yang J; Martinez-Escala ME; Moy AP; Morgan EA; Paxton CN; Hong B; Andersen EF; Guitart J; Behdad A; Cerroni L; Weinstock DM; Choi J
J Invest Dermatol; 2018 Nov; 138(11):2365-2376. PubMed ID: 29857068
[TBL] [Abstract][Full Text] [Related]
8. MYD88, CARD11, and CD79B Oncogenic Mutations are Rare Events in the Indian Cohort of De Novo Nodal Diffuse Large B-Cell Lymphoma.
Aggarwal V; Das A; Bal A; Srinivasan R; Das R; Prakash G; Malhotra P; Varma S
Appl Immunohistochem Mol Morphol; 2019 Apr; 27(4):311-318. PubMed ID: 29734251
[TBL] [Abstract][Full Text] [Related]
9. Diffuse large B-cell lymphoma patient-derived xenograft models capture the molecular and biological heterogeneity of the disease.
Chapuy B; Cheng H; Watahiki A; Ducar MD; Tan Y; Chen L; Roemer MG; Ouyang J; Christie AL; Zhang L; Gusenleitner D; Abo RP; Farinha P; von Bonin F; Thorner AR; Sun HH; Gascoyne RD; Pinkus GS; van Hummelen P; Wulf GG; Aster JC; Weinstock DM; Monti S; Rodig SJ; Wang Y; Shipp MA
Blood; 2016 May; 127(18):2203-13. PubMed ID: 26773040
[TBL] [Abstract][Full Text] [Related]
10. Clinicopathological features of 49 primary gastrointestinal diffuse large B-cell lymphoma cases; comparison with location, cell-of-origin, and frequency of MYD88 L265P.
Nagakita K; Takata K; Taniguchi K; Miyata-Takata T; Sato Y; Tari A; Ohnishi N; Noujima-Harada M; Omote S; Nakamura N; Iwamuro M; Maeda Y; Okada H; Tanimoto M; Yoshino T
Pathol Int; 2016 Aug; 66(8):444-52. PubMed ID: 27439595
[TBL] [Abstract][Full Text] [Related]
11. Oncogenic Mutations and Tumor Microenvironment Alterations of Older Patients With Diffuse Large B-Cell Lymphoma.
Zhu Y; Fu D; Shi Q; Shi Z; Dong L; Yi H; Liu Z; Feng Y; Liu Q; Fang H; Cheng S; Wang L; Tian Q; Xu P; Zhao W
Front Immunol; 2022; 13():842439. PubMed ID: 35401516
[TBL] [Abstract][Full Text] [Related]
12. MYD88, CD79B, and CARD11 gene mutations in CD5-positive diffuse large B-cell lymphoma.
Takeuchi T; Yamaguchi M; Kobayashi K; Miyazaki K; Tawara I; Imai H; Ono R; Nosaka T; Tanaka K; Katayama N
Cancer; 2017 Apr; 123(7):1166-1173. PubMed ID: 27915469
[TBL] [Abstract][Full Text] [Related]
13. Discovery and prioritization of somatic mutations in diffuse large B-cell lymphoma (DLBCL) by whole-exome sequencing.
Lohr JG; Stojanov P; Lawrence MS; Auclair D; Chapuy B; Sougnez C; Cruz-Gordillo P; Knoechel B; Asmann YW; Slager SL; Novak AJ; Dogan A; Ansell SM; Link BK; Zou L; Gould J; Saksena G; Stransky N; Rangel-Escareño C; Fernandez-Lopez JC; Hidalgo-Miranda A; Melendez-Zajgla J; Hernández-Lemus E; Schwarz-Cruz y Celis A; Imaz-Rosshandler I; Ojesina AI; Jung J; Pedamallu CS; Lander ES; Habermann TM; Cerhan JR; Shipp MA; Getz G; Golub TR
Proc Natl Acad Sci U S A; 2012 Mar; 109(10):3879-84. PubMed ID: 22343534
[TBL] [Abstract][Full Text] [Related]
14. High prevalence of oncogenic MYD88 and CD79B mutations in diffuse large B-cell lymphomas presenting at immune-privileged sites.
Kraan W; Horlings HM; van Keimpema M; Schilder-Tol EJ; Oud ME; Scheepstra C; Kluin PM; Kersten MJ; Spaargaren M; Pals ST
Blood Cancer J; 2013 Sep; 3(9):e139. PubMed ID: 24013661
[TBL] [Abstract][Full Text] [Related]
15. Comparative analysis of primary
Greenawalt DM; Liang WS; Saif S; Johnson J; Todorov P; Dulak A; Enriquez D; Halperin R; Ahmed A; Saveliev V; Carpten J; Craig D; Barrett JC; Dougherty B; Zinda M; Fawell S; Dry JR; Byth K
Oncotarget; 2017 Nov; 8(59):99237-99244. PubMed ID: 29245897
[TBL] [Abstract][Full Text] [Related]
16. Whole-Genome/Exome Sequencing Uncovers Mutations and Copy Number Variations in Primary Diffuse Large B-Cell Lymphoma of the Central Nervous System.
Zhu Q; Wang J; Zhang W; Zhu W; Wu Z; Chen Y; Chen M; Zheng L; Tang J; Zhang S; Wang D; Wang X; Chen G
Front Genet; 2022; 13():878618. PubMed ID: 35646048
[No Abstract] [Full Text] [Related]
17. Genomic landscape and distinct molecular subtypes of primary testicular lymphoma.
Zhang W; Yang P; Yang Y; Liu S; Xu Y; Wu C; Wang J; Liu C; Liu H; Li S; Huang W; Jing H
J Transl Med; 2024 May; 22(1):414. PubMed ID: 38693538
[TBL] [Abstract][Full Text] [Related]
18. Genomic complexity is associated with epigenetic regulator mutations and poor prognosis in diffuse large B-cell lymphoma.
You H; Xu-Monette ZY; Wei L; Nunns H; Nagy ML; Bhagat G; Fang X; Zhu F; Visco C; Tzankov A; Dybkaer K; Chiu A; Tam W; Zu Y; Hsi ED; Hagemeister FB; Huh J; Ponzoni M; Ferreri AJM; Møller MB; Parsons BM; Van Krieken JH; Piris MA; Winter JN; Li Y; Au Q; Xu B; Albitar M; Young KH
Oncoimmunology; 2021; 10(1):1928365. PubMed ID: 34350060
[TBL] [Abstract][Full Text] [Related]
19. Rare cases of primary central nervous system anaplastic variant of diffuse large B-cell lymphoma.
Xu T; Jia Q; Wang Y; Liu Y; Han D; Li P; Ma J; Fan L; Yan Q; Guo S; Li M; Wang Z
Diagn Pathol; 2019 May; 14(1):45. PubMed ID: 31109360
[TBL] [Abstract][Full Text] [Related]
20. Genetic Landscape of Relapsed and Refractory Diffuse Large B-Cell Lymphoma: A Systemic Review and Association Analysis With Next-Generation Sequencing.
Gao F; Tian L; Shi H; Zheng P; Wang J; Dong F; Hu K; Ke X
Front Genet; 2021; 12():677650. PubMed ID: 34925435
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]